Skip to the page

Data / Form D filings / Medsender, Inc.

Medsender, Inc.: Form D filing

Medsender, Inc., a health care company in New York, NY, filed a Form D with the SEC in 2025. The latest, on January 29, 2025, reports $7.5 million sold of a $7.5 million offering to 31 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
447 BROADWAY, FLOOR 2, New York, NY, 10013
Phone
(929) 274-0002
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2053890

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 29, 2025New notice$7,494,999$7,494,99931Jan 13, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Salman HaqueExecutive Officer, Director
Jainal BhuiyanDirector
Matthew RiceDirector
Zain QayyumExecutive Officer, Director

Other health care companies in New York that filed recently

Every Form D from the week of Jan 27, 2025 · All recent filings in New York · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Medsender, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.